Description

Melsmon Injection — Japanese Human Placenta Extract

Melsmon Injection is a human placenta hydrolysate from Melsmon Pharmaceutical Co., Ltd. in Japan. The Japanese Ministry of Health, Labour and Welfare first approved it in 1956, giving it one of the longest continuous track records of any placenta-derived pharmaceutical in the world.

Each vial contains a concentrated mix of amino acids, active peptides, growth factors, vitamins, and minerals extracted from human placenta. Because of this dense biological profile, practitioners use Melsmon for both its officially approved medical indications and its widely recognized role in skin rejuvenation.

Each box contains 50 ampoules of 2mL, with 100mg of placenta hydrolysate per vial.

Korea Filler Experts offers Melsmon Injection and ships it worldwide.

Key Benefits

• Backed by a 65+ year history of clinical use in Japan
• Supports relief from menopausal symptoms, including hot flashes and fatigue
• May help support lactation in postpartum patients
• Supports skin elasticity, hydration, and cellular regeneration
• Associated with improvement in hyperpigmentation and dark spots
• Undergoes rigorous viral screening and purification during manufacturing

What’s Inside

Active Ingredient	Human Placenta Hydrolysate — 100mg per 2mL vial
Key Components	Amino acids, active peptides, growth factors, vitamins, minerals, mucopolysaccharides
Other Ingredients	Benzyl alcohol (preservative), sodium hydroxide
Packing	2mL × 50 ampoules per box
Shelf Life	24 months, unopened
Manufacturer	Melsmon Pharmaceutical Co., Ltd., Japan

Manufacturing & Safety

Melsmon Pharmaceutical sources placentas only from healthy, thoroughly screened donors, with each batch tracked by donor number. Every placenta undergoes viral testing, confirming it’s negative for HBV, HCV, and HIV before use as raw material.

During production, the manufacturer heat-treats the extract using hydrochloric acid. This process breaks down hormones and proteins in the raw material. It also addresses prion-related safety concerns. Since the product’s introduction in 1956, no serious adverse effects have been reported in connection with its use.

Indications

In Japan, Melsmon carries official approval for:

• Menopausal symptoms, including hot flashes, cold sensitivity, insomnia, irritability, headaches, fatigue, and stiff neck or shoulders
• Poor lactation following childbirth

Beyond these approved uses, practitioners in cosmetology widely use Melsmon for skin rejuvenation, addressing concerns like hyperpigmentation, dullness, and reduced elasticity.

How Melsmon Injection Works

Placenta hydrolysate carries a dense concentration of amino acids and active peptides. These components support cellular repair and regeneration throughout the body. Because the formula includes hormonal precursors and growth factors, it’s associated with effects reaching beyond the skin. These include support for energy levels and hormonal balance.

On the skin specifically, the formula’s peptides and growth factors support collagen-related processes and cellular turnover, contributing to the elasticity and hydration benefits many patients report with regular treatment.

Administration

Practitioners typically administer Melsmon via subcutaneous injection, though intramuscular administration is also used. Common protocols include:

• One vial every 2 to 3 days for the first 1 to 2 months
• For pigmentation concerns: 2mL subcutaneously every 7 to 10 days
• For post-procedure recovery (after laser, peel, or surgery): 2mL intramuscularly every 5 days for 4 to 6 weeks

Response time varies by patient. Some notice changes within a week, while others may need up to 60 days to see meaningful results.

Precautions

• For use by licensed medical professionals only
• Contraindicated during pregnancy
• Contraindicated in patients with active malignancy or cancer
• Use caution in patients with autoimmune conditions under immunosuppressive therapy
• Mild side effects can include pain or redness at the injection site, chills, fever, or rash — report these to a physician if they occur

Storage & Handling

• Store at 2–8°C, protected from light
• Do not freeze
• Use promptly after opening

Frequently Asked Questions

What is Melsmon Injection?
Melsmon Injection is a Japanese human placenta hydrolysate from Melsmon Pharmaceutical, approved since 1956 for menopausal symptoms and lactation support, and widely used in cosmetology for skin rejuvenation.

How is Melsmon different from Laennec?
Both are human placenta extracts, but Melsmon comes specifically from Melsmon Pharmaceutical in Japan with its own distinct approval history since 1956, while Laennec is manufactured using JBP’s extraction technology.

How long before results appear?
This varies by patient. Some notice changes within about a week, while others may need up to 60 days for meaningful results.

Who should avoid Melsmon Injection?
Patients who are pregnant, have active malignancy, or are undergoing immunosuppressive therapy for autoimmune conditions should avoid it.

---

Buy Melsmon Injection online from Korea Filler Experts, a trusted wholesale supplier of premium aesthetic and medical products. We ship worldwide.